Xinlan Shi

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Research developments on the histopathology and prognostic predictors of serous borderline tumor of ovary

X. Shi, Chunxiang Zhao, Xinlan Shi, 2009 .

Nomogram model predicting the overall survival for patients with primary gastric mucosa-associated lymphoid tissue lymphoma

R. Shi, Dan Wang, Xinlan Shi, 2023, World journal of gastrointestinal oncology.